BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 3954531)

  • 1. Treatment of mitomycin-associated microangiopathic hemolytic anemia with vincristine.
    Grem JL; Merritt JA; Carbone PP
    Arch Intern Med; 1986 Mar; 146(3):566-8. PubMed ID: 3954531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Microangiopathic hemolytic anemia (MAHA) observed after administration of mitomycin C (MMC)].
    Yasunaga C; Komota T; Mimura K; Kinjyo M; Sueishi K; Hirose T
    Gan No Rinsho; 1987 Jun; 33(7):854-60. PubMed ID: 3112442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Microangiopathic hemolytic anemia (MAHA) and renal failure induced by anti-neoplastic agents--a case report].
    Sagawa M; Sakuma T; Takahashi S; Usuda K; Satoh M; Kamma K; Ohta S; Nagamoto N; Imai T; Saitoh Y
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2564-7. PubMed ID: 3039922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microangiopathic hemolytic anemia, renal failure, and noncardiogenic pulmonary edema: a chemotherapy-induced syndrome.
    Jolivet J; Giroux L; Laurin S; Gruber J; Bettez P; Band PR
    Cancer Treat Rep; 1983 May; 67(5):429-34. PubMed ID: 6406059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microangiopathic hemolytic anemia, noncardiac pulmonary edema, and renal failure after treatment of metastatic adenocarcinoma of the colon with 5-fluorouracil and mitomycin-C: report of a case.
    Claycomb CL; Berkovic M
    J Am Osteopath Assoc; 1986 Aug; 86(8):499-503. PubMed ID: 3093413
    [No Abstract]   [Full Text] [Related]  

  • 6. Microangiopathic hemolytic anemia, a frequent complication of mitomycin therapy in cancer patients.
    Bruntsch U; Groos G; Tigges FJ; Gallmeier WM
    Eur J Cancer Clin Oncol; 1984 Jul; 20(7):905-9. PubMed ID: 6540191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Microangiopathic hemolytic anemia associated with gastric cancer].
    Kanou T; Nosou Y; Yoshinaka K; Yanagawa E; Niimoto M; Hattori T; Miura K; Kuramoto J
    Gan No Rinsho; 1986 Aug; 32(9):1029-34. PubMed ID: 3091884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microangiopathic hemolytic anemias (MAHA) in cancer. A case report and review.
    Nordström B; Strang P
    Anticancer Res; 1993; 13(5C):1845-9. PubMed ID: 8267391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Three cases of renal failure associated with microangiopathic hemolytic anemia after mitomycin C therapy].
    Hayano K; Fukui H; Otsuka Y; Hattori S
    Nihon Jinzo Gakkai Shi; 1988 Jul; 30(7):835-42. PubMed ID: 3150472
    [No Abstract]   [Full Text] [Related]  

  • 10. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.
    Cantrell JE; Phillips TM; Schein PS
    J Clin Oncol; 1985 May; 3(5):723-34. PubMed ID: 3923162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microangiopathic anemia observed after treatment of epidermoid carcinoma with mitomycin C and 5-fluorouracil.
    Gulati SC; Sordillo P; Kempin S; Reich L; Magill GB; Scheiner E; Clarkson B
    Cancer; 1980 May; 45(9):2252-7. PubMed ID: 7379025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Two cases with microangiopathic hemolytic anemia caused by anti-cancer drugs who improved rapidly after administration of aspirin and dipyridamole].
    Ito S; Hirono S
    Rinsho Ketsueki; 1982 May; 23(5):730-5. PubMed ID: 6813535
    [No Abstract]   [Full Text] [Related]  

  • 13. Pulmonary hypertension, hemolytic anemia, and renal failure. A mitomycin-associated syndrome.
    McCarthy JT; Staats BA
    Chest; 1986 Apr; 89(4):608-11. PubMed ID: 3082608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Microangiopathic hemolytic anemia associated with mitomycin-C treatment].
    Godes M; Camps C; Martínez A
    An Med Interna; 1991 Dec; 8(12):611-3. PubMed ID: 1782316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Microangiopathic haemolytic anaemia as a complication of mitomycin C treatment (author's transl)].
    Tigges FJ; Bruntsch U; Groos G; Gallmeier WM
    Dtsch Med Wochenschr; 1982 Jan; 107(4):142-5. PubMed ID: 7056168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology and management of thrombotic microangiopathies.
    Ruggenenti P; Remuzzi G
    J Nephrol; 1998; 11(6):300-10. PubMed ID: 10048496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible microangiopathic hemolytic anemia after mitomycin C.
    Perry DJ
    Cancer Chemother Pharmacol; 1983; 10(3):223. PubMed ID: 6407770
    [No Abstract]   [Full Text] [Related]  

  • 18. Mitomycin-induced hemolytic-uremic syndrome.
    Proia AD; Harden EA; Silberman HR
    Arch Pathol Lab Med; 1984 Dec; 108(12):959-62. PubMed ID: 6210069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary veno-occlusive disease associated with microangiopathic hemolytic anemia and chemotherapy of gastric adenocarcinoma.
    Waldhorn RE; Tsou E; Smith FP; Kerwin DM
    Med Pediatr Oncol; 1984; 12(6):394-6. PubMed ID: 6548790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mytomycin C nephrotoxicity. 3 new cases and review of the literature].
    Simon P; Hervé JP; Ramée MP; Leroy JP; Ang KS; Leguy P; Vignoud J; Cledes J
    Nephrologie; 1982; 3(4):152-7. PubMed ID: 6818483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.